A study to improve total management of ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study will track the health of people being treated for ovarian cancer at Sichuan Cancer Hospital. It aims to learn how to better manage all aspects of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with ovarian cancer (including fallopian tube or primary peritoneal cancer).
- You plan to receive your cancer treatment at Sichuan Cancer Hospital.
- You are willing to attend follow-up visits after treatment.
- You do not have any other cancer, and haven't had one in the past.
- You do not have any condition that affects your memory, thinking, or decision-making.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at metastatic ovarian cancer by analyzing many types of patient data (from “multi-omics,” which means different kinds of lab and biological information). It may help doctors better understand the disease and improve future care.
This study aims to improve care for ovarian cancer by including people at different stages: those being checked for it, those with known risk factors, and those who are generally healthy. It could help researchers better understand and support patients and their families.
This study tests a new maintenance treatment (sacituzumab tirumotecan) versus standard care for people with ovarian cancer that has come back after responding to platinum-based chemotherapy. The goal is to see if it can keep the cancer from growing longer and improve quality of life.
This trial tests two drugs (fluzoparib with famitinib or SHR-1701) given before surgery to shrink advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if these treatments can make tumors small enough for complete removal or improve the surgery outcome.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This trial is creating a detailed registry of genetic changes found in ovarian tumors in Taiwan. It aims to better understand the disease by collecting tumor tissue and blood samples from patients with high-grade serous or clear cell ovarian, fallopian tube, or peritoneal cancer.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.